Age
Item
minimum age 18 years
boolean
C0001779 (UMLS CUI [1])
primary basal cell carcinoma, histologically confirmed
Item
primary basal cell carcinoma, histologically confirmed
boolean
C1304305 (UMLS CUI [1,1])
C0449575 (UMLS CUI [1,2])
(micro) nodular or superficial histological subtype
Item
(micro) nodular or superficial histological subtype
boolean
C0862889 (UMLS CUI [1])
C4083056 (UMLS CUI [2])
comorbidities may not interfere with study treatment
Item
comorbidities may not interfere with study treatment
boolean
C0009488 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
capable to understand instructions
Item
capable to understand instructions
boolean
C2051542 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C2698977 (UMLS CUI [1,3])
Age
Item
age under 18 years
boolean
C0001779 (UMLS CUI [1])
tumors located at the h-zone of the face
Item
tumors located at the h-zone of the face
boolean
C0007117 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
C0015450 (UMLS CUI [1,3])
deficient histological conformation
Item
deficient histological conformation
boolean
C0679557 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
proven or suspected malignancy of other organs
Item
proven or suspected malignancy of other organs
boolean
C0581833 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0178784 (UMLS CUI [1,3])
C0205394 (UMLS CUI [2,1])
C0178784 (UMLS CUI [2,2])
C0006826 (UMLS CUI [2,3])
not capable of comprehending instructions
Item
not capable of comprehending instructions
boolean
C2051542 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
C2698977 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Incompetent
Item
incompetent
boolean
C0231190 (UMLS CUI [1])
Recent or current use of oral nsaids
Item
use of oral nsaids during the trial period or within 30 days before starting therapy
boolean
C0003211 (UMLS CUI [1,1])
C0442027 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C0442027 (UMLS CUI [2,2])
C0521116 (UMLS CUI [2,3])
Recent or current use of oral vitamin d (containing) supplements
Item
use of oral vitamin d (containing) supplements during the trial period or within 30 days before starting therapy
boolean
C3215522 (UMLS CUI [1,1])
C0242297 (UMLS CUI [1,2])